Overview

3VM1001 Cream for the Treatment of Pain Associated With Post Herpetic Neuralgia (PHN)

Status:
Completed
Trial end date:
2018-05-04
Target enrollment:
Participant gender:
Summary
Post-herpetic neuralgia (PHN) is pain following acute herpes zoster; defined as pain lasting longer than 3 months. Current first line management consists of tricyclic anti-depressants and anti-convulsants such as gabapentin and pregabalin. There is an unmet medical need for treatments got topical therapies that demonstrate efficacy without serious side effects.
Phase:
Early Phase 1
Details
Lead Sponsor:
CDA Research Group, Inc.